Clinical Quantitative Mass Spectrometry Proteomics (WG-cMSP)
Membership
|
Name |
Position |
Country |
Term |
Time in
Office |
| S. Lehmann |
Chair |
FR |
1st |
2011 01 - 2013 12 |
| E.O. Agbedana |
Member |
NG |
|
|
| Y. Ando |
Member |
JP |
|
|
| C. Brede |
Member |
NO |
|
|
| U. Ceglarek |
Member |
DE |
|
|
| J.A. Cocho |
Member |
ES |
|
|
| M. Glückmann |
Member |
DE |
|
|
| Y. Gong |
Member |
CA |
|
|
| D. Hochstrasser |
Member |
CH |
|
|
| A. Hoofnagle |
Member |
US |
|
|
| BE. Krastin |
Member |
US |
|
|
| C. Queijo |
Member |
UY |
|
|
| A. Urbani |
Member |
IT |
Terms of Reference
- To review the state of the art in quantitative proteomics and
to evaluate the capacity of different analytical (and
preanalytical) approaches to play in the future a significant role
for clinical biology
- To evaluate the specification and the need for reference
materials for quantitative proteomics applied to clinical
biology
- To design of a Quality Assurance/Quality Control (QA/QC)
Program and to select a small series of analytes to be the subject
of a future multi-site validation study
Current Projects
- Collect information related to the above "Terms of Reference"
to propose a "road map/white paper" on "Clinical Chemistry
Proteomics", i.e. the application of Clinical Proteomics to
Clinical Chemistry
- Decision on the optimum analyte for the assessment of Clinical
Quantitative Mass Spectrometry Proteomics in a multi-site
validation study.
- Organize a symposia/session in a future international
meeting
- Coordination with HUPO/EuPA latest initiatives on the Human
Proteome Project and in particular on the mass spectrometry based
quantitative assays.
Working Group Chairs' contact
Prof. Sylvain LEHMANN
CHU de Montpellier - Hôpital St. Eloi
Institut de Recherches en Biothérapie (IRB)
Biochimie - Protéomique Clinique
80, av A. Fliche
34295 Montpellier Cedex 5
FRANCE
Tel: +33 04 67 33 71 23 / +33 04 67 33 71 24
Fax: +33 04 67 33 69 21
E-mail: s-lehmann@chu-montpellier.fr